Literature DB >> 29188071

Postoperative Tropheryma whipplei endophthalmitis - a case report highlighting the additive value of molecular testing.

Julia Dick1, Patrizia Krauß2, Jost Hillenkamp2, Britta Kohlmorgen1, Christoph Schoen1.   

Abstract

Introduction.Tropheryma whipplei is the causative agent of Whipple's disease. Gastrointestinal and lymphatic tissues are affected in the majority of cases, resulting in diarrhoea, malabsorption and fever. Here, we report a rare case of ocular manifestation in a patient lacking the typical Whipple symptoms. Case presentation. A 74-year-old Caucasian female presented with blurred vision in the right eye over a period of 1-2 months, accompanied by stinging pain and conjunctival hyperaemia for the last 2 days. Upon admission, visual acuity was hand motion in the affected eye. Ophthalmological examination showed typical signs of intraocular inflammation. Diagnostic and therapeutic pars plana vitrectomy including vitreous biopsy and intravitreal instillation of vancomycin and amikacin was performed within hours of initial presentation. Both microscopic analysis and microbial cultures of the vitreous biopsy remained negative for bacteria and fungi. The postoperative antibiotic regime included intravenous administration of ceftriaxone in combination with topical tobramycin and ofloxacin. Due to the empirical therapy the inflammation ceased and the patient was discharged after 5 days with cefpodoxime orally and local antibiotic and steroidal therapy. Meanwhile, the vitreous body had undergone testing by PCR for the eubacterial 16S rRNA gene, which was found to be positive. Analysis of the PCR product revealed a specific sequence of T. whipplei. Conclusion. In our patient, endophthalmitis was the first and only symptom of Morbus Whipple, while most patients with Whipple's disease suffer from severe gastrointestinal symptoms. 16S rDNA PCR should be considered for any intraocular infection when microscopy and standard culture methods remain negative.

Entities:  

Keywords:  Tropheryma whipplei; Whipple's disease; endophthalmitis; intravenous ceftriaxone; intravitreal vancomycin and amikacin; ocular infection; oral cefpodoxime; oral doxycycline; topic ofloxacin; vitrectomy

Year:  2017        PMID: 29188071      PMCID: PMC5692240          DOI: 10.1099/jmmcr.0.005124

Source DB:  PubMed          Journal:  JMM Case Rep        ISSN: 2053-3721


Abbreviation

WD, Whipple’s disease.

Introduction

Tropheryma whipplei is a bacterium of the phylum Actinobacteria and causes Whipple’s disease (WD) [1]. The rod-shaped bacterium can be visualized by electron microscopy; diagnostic identification by light microscopy fails, as T. whipplei cannot be stained with conventional dyes. Culturing is difficult; the first stable cultures of T. whipplei were established only in 2000 [2]. Standard culturing methods used in diagnostic bacteriology laboratories do not provide sufficient substrate for this fastidious bacillus. WD was first described in 1907 by George H. Whipple and was suspected to be an infectious disease [3]. Although pathognomonic periodic acid-Schiff (PAS) inclusions in the cytoplasm of macrophages were visible in the majority of tissue samples from Whipple patients, the causative bacterium was not identified until 1992 [4]. WD is characterized by diarrhoea, abdominal pain and arthralgia [5]. Weight loss and fever are common, which may be misinterpreted as B-symptoms. Epidemiological data are difficult to obtain for the disease; estimates on the basis of indirect evidence suggest a prevalence of about 1 : 1 000 000 and an annual incidence of one to six per 10 million inhabitants [6]. Because of the rarity of the disease, controlled randomized therapeutic trials are difficult. Therefore, antibiotic treatment strategies are often derived from long-term follow-up case reports [7]. Among WD patients, ocular involvement is rare and is usually a late manifestation. The dimension of ocular WD is heterogeneous, and can be found as uveitis, chorioiditis, retinitis, keratitis and endophthalmitis as well as neuro-ophthalmological disease, often correlated with central nervous system infection [8]. Most patients with eye involvement state gastrointestinal symptoms or have been previously diagnosed with WD [9]. Here, we report a rare case of postoperative endophthalmitis in a patient lacking the typical Whipple symptoms.

Case report

A 74-year-old Caucasian female presented with a 1–2 month history of blurred vision of the right eye, accompanied by stinging pain and conjunctival hyperaemia for the last 2 days. The patient had undergone cataract surgery on the left eye 7 months earlier and on the affected right eye 4 months earlier. At time of admission she was treated with cortisone eye drops due to a purulent conjunctivitis that developed about 1 week prior to admission. A urinary tract infection had been treated with ciprofloxacin until 2 days before admission. General history included chronic lymphatic leukaemia for a period of 30 years, Parkinson’s disease, status post-melanoma and post-hip replacement surgery. The patient was allergic to cotrimoxazole. Upon admission, visual acuity was hand motion in the right eye and 0.4 (decimal acuity) in the left eye, and intraocular pressures were 14 mmHg in the right eye and 16 mmHg in the left eye. Ophthalmological examination of the right eye showed Descemet membrane folds, hypopyon, anterior chamber inflammation, endothelial cells and fibrin coating on the back face of the intraocular lens. The vitreous body showed inflammatory cells and streaks. Fundoscopy revealed a whitish retinal lesion with blurred margins in the lower midperiphery. The left eye did not show any signs of intraocular inflammation. The patient was presumptively diagnosed with acute endophthalmitis of the right eye.

Investigations

Within a few hours of admission, the patient underwent vitrectomy including vitreous biopsy. The specimen was examined microscopically and microbial culturing was initiated immediately. Culturing included plating on Columbia agar with 5 % sheep blood (bioMérieux) and chocolate agar [Becton Dickinson (BD)], and liquid culturing in thioglycollate medium (BD) and Sabouraud broth with 4 % glucose (in-house product). In total, 200 µl was retained and stored at 4 °C for molecular testing on the following working day. Microscopic examination of the vitreous body showed neither bacteria nor fungi in the Gram stain. Microbial cultures of the vitreous biopsy remained negative for 12 days. Meanwhile, the vitreous body had undergone testing by PCR for the eubacterial 16S rRNA gene (Fig. 1a), which was found to be positive (primers: BAK 5′-AGTTTGATCHTGGCTCAG-3′ and PC3mod 5′-GGACTACHAGGGTATCTAAT-3’; anticipated amplicon size about 800 bp [10, 11]). The result was documented with a QIAxcel ScreenGel system (Qiagen), and the amplicon was subjected to Sanger sequencing with subsequent alignment against five databases: NCBI nucleotide blast, leBIBI, SepsiTest, Greengenes and RDP_II [12-16].
Fig. 1.

Products of (a) 16S rRNA PCR and (b) T. whipple i-specific PCR, documented with the QIAxcel ScreenGel system (Qiagen). The size of the amplicon from the eubacterial 16S rRNA PCR is about 800 bp, which is somewhat species-dependent. In the T. whipplei-specific PCR, the anticipated size is 284 bp. M: marker with band sizes as indicated, N: negative control, P: positive control, S: patient sample.

Products of (a) 16S rRNA PCR and (b) T. whipple i-specific PCR, documented with the QIAxcel ScreenGel system (Qiagen). The size of the amplicon from the eubacterial 16S rRNA PCR is about 800 bp, which is somewhat species-dependent. In the T. whipplei-specific PCR, the anticipated size is 284 bp. M: marker with band sizes as indicated, N: negative control, P: positive control, S: patient sample. Surprisingly, sequence analysis of the product indentified T. whipplei, which was confirmed by a positive T. whipplei-specific PCR (primers: pW3FE 5′-GGAATTCCAGAGATACGCCCCCCGCAA-3′ and pW2RB 5′-CGGGATCCCATTCGCTCCACCTTGCGA-3′; anticipated amplicon size 284 bp [4]) (Fig. 1b).

Diagnosis

Clinical examination along with molecular testing thus confirmed the diagnosis of postoperative endophthalmitis caused by T. whipplei.

Treatment

Diagnostic and therapeutic pars plana vitrectomy including surgical capsulotomy, lavage of the anterior chamber and intravitreal instillation of vancomycin and amikacin were performed within hours of initial presentation. The postoperative antibiotic regime included intravenous administration of ceftriaxone in combination with hourly topical tobramycin and ofloxacin. Prednisolone acetate eye drops four times per day and cyclopentolate eye drops twice per day were applied as supportive local therapy. Microbial cultures of the vitreous biopsy remained negative for 12 days. Screening for a source of infection included urine examination, which was sterile but positive for erythrocytes and leucocytes consistent with the pre-existing cystitis. X-ray of the left hip showed no focus of infection. Due to the empirical therapy the inflammation ceased and the patient was discharged after 5 days with oralized antibiotic admission of cefpodoxime 200 mg twice a day and local antibiotic and steroidal therapy. Decimal visual acuity on the right eye had improved to 0.5 on discharge.

Outcome and follow-up

Four weeks later the patient presented for follow-up. Decimal visual acuity then was 0.8 in the right eye and 0.7 in the left eye; intraocular pressures were 13 and 14 mmHg. No intraocular inflammation was detectable, so local therapy was stopped. During follow-up care the patient was informed about the pathogen found in the vitreous fluid, and about WD. The consequences, such as the importance of further diagnostic procedures such as lumbar puncture for cerebrospinal fluid examination and duodenoscopy to exclude multi-organ involvement of WD and the schedule for antibiotic treatment, were discussed together with the patient, her immediate family and physicians from the Department of Ophthalmology and the Institute for Hygiene and Microbiology. The patient declined further invasive diagnostic treatment because of her pre-existing morbidity; however, she agreed to empirical antibiotic treatment. In consent with the patient, we recommended a long-term-antibiotic oral therapy for treatment of WD without further diagnostic investigation. Due to the patient’s allergy to cotrimoxazole, doxycycline treatment was scheduled with 100 mg twice per day for at least 1 year.

Discussion

In this report, we describe a rare case of postoperative eye infection in which T. whipplei was identified as the causative agent. Empirical treatment with instillation of vancomycin and amikacin plus topical ofloxacin, supported by intravenous ceftriaxone and oral cefpodoxime, respectively, led to significant improvement of the patient’s symptoms before the pathogen could be identified. Eye infections after eye surgery or intravitreal injections performed in an operating room are commonly caused by coagulase-negative staphylococci and other Gram-positive bacteria [17, 18]. Postoperative endophthalmitis caused by T. whipplei is extremely rare. On describing the first case of postoperative ocular WD in 2008, Drancourt et al. retrospectively analysed cases of Whipple eye infections [19]. Among 19 patients, 11 had undergone eye surgery prior to diagnosis of Whipple uveitis [20]. Similar to our patient, they had received topical steroids in the context of cataract surgery and then developed symptoms of chronic postoperative pan-endophthalmitis. Other clinical manifestations of eye involvement in WD were described earlier, such as vitritis, (chorio-)retinitis, (pan-)uveitis, papilloedema, optical atrophy, retinal haemorrhage and crystalline keratopathy [21-29]. Chiquet et al. showed that identification of bacteria in endophthalmitis patients by culturing may lead to false-negative results, especially when the patient has received antibiotics before the sample is drawn, and concluded that eubacterial PCR should be performed complementary to standard microbial culturing [30]. This procedure is also recommended by the guidelines on endophthalmitis following cataract surgery of the European Society of Cataract and Refractive Surgery [31]. Evaluation of data obtained in the diagnostic laboratory of the Institute for Hygiene and Microbiology at the University of Würzburg over a 3-year period (2014–2016) showed 46 cases of suspected bacterial endophthalmitis that had been examined via conventional microbial culture and 16S rDNA PCR plus sequencing as described above. Twenty-one vitreous body aspirates, 10 aqueous humour samples and 15 aspirates of undefined origin were included. In 22 cases, cultures remained sterile; among material from these 22 cases, four were detected as positive by 16S rDNA PCR. Thus, 18 % of all specimens without evidence of microbial growth were found to give false-negative results. Sequence analysis of the 16S rRNA gene revealed viridians streptococci, Moraxella nonliquefaciens, T. whipplei and one polymicrobial infection. Identification was based on sequence alignment with five different databases: NCBI nucleotide blast, leBIBI, SepsiTest, Greengenes and RDP_II [12-16]. Fastidious bacteria were exclusively identified by PCR, while Gram-positive cocci as the most common pathogens in postoperative eye infections could be diagnosed by culture and verified by PCR. A possible explanation for the positive PCR and negative culture results is the loss of bacterial viability, which may occur if the sample transportation exceeds the critical time limit for fastidious bacteria [32, 33]. Nonetheless, bacterial DNA is still present in these samples and can be detected by PCR. In three cases, cultures showed growth of Staphylococcus epidermidis or Propionibacterium acnes, while the native aspirate tested negative by PCR. This might be due to the fact that the sensitivity of the 16S rDNA PCR employed was limited to 100 genome equivalents in aqueous solution to reduce the number of false-positive results caused by spurious amounts of pervasive bacterial DNA. In contrast, microbial culture is significantly more sensitive for non-fastidious bacteria. Another explanation might be the degradation of bacterial DNA during storage, as PCR is routinely performed only during weekdays at our microbiology department and samples are meanwhile kept at 4 °C [34, 35]. However, we cannot exclude the possibility that these cultures might have been contaminated and the PCR had therefore remained sterile (Table 1).
Table 1.

Bacteria identified from vitreous or aqueous humour samples of patients with diagnosed endophthalmitis over a 3-year period (2014–2016)

Result Total PCR Culture Both
Positive27232218
Staphylococcus epidermidis 119119
Staphylococcus aureus 2222
 Oral streptococci5544
Streptococcus pneumoniae/pseudopneumoniae 2222
Serratia marscescens 1111
Propionibacterium acnes 1010
Tropheryma whipplei 1100
Moraxella nonliquefaciens 1100
 Other2110
 Not distinguishable (PCR≥2 species)1100
Negative19232428

Conclusion

This report shows how standard microbiological culturing may fail to identify the causative agent of acute endophthalmitis and emphasizes the importance of complementary methods, such as 16S rDNA PCR. Postoperative eye infections due to T. whipplei are extremely rare; nonetheless, 16S rDNA PCR should be routinely performed on vitreous samples additional to standard microbial culturing to identify fastidious bacteria.
  30 in total

1.  Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis.

Authors:  Michel Drancourt; Didier Raoult; Hubert Lépidi; Florence Fénollar; Marie-Laure Birg; Bahram Bodaghi; Phuc Le Hoang; Jean-Daniel Lelièvre
Journal:  Ann Intern Med       Date:  2003-12-16       Impact factor: 25.391

2.  Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.

Authors:  T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

3.  Rare but not so rare: The evolving spectrum of Whipple's disease.

Authors:  J M Conly; B L Johnston
Journal:  Can J Infect Dis       Date:  2001-05

4.  Whipple's disease involving the eye, the brain, the heart and the gut diagnosed through the eye.

Authors:  Shahin Gaïni; Niels Eske Bruun; Rudi Kollslíð; Heðin Thomsen; Torkil á Steig; Kári Rubek Nielsen; Marija Todorovic Markovic; Elin Holm
Journal:  Acta Ophthalmol       Date:  2014-07-10       Impact factor: 3.761

5.  Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus.

Authors:  B La Scola; F Fenollar; P E Fournier; M Altwegg; M N Mallet; D Raoult
Journal:  Int J Syst Evol Microbiol       Date:  2001-07       Impact factor: 2.747

6.  Can't hear, can't see, and too sore to play.

Authors:  Ryan A Scheurer; Gregory S Kosmorsky; Gary S Hoffman; Carol Farver; Michael S Lee; Dean M Cestari
Journal:  Surv Ophthalmol       Date:  2010-01-18       Impact factor: 6.048

7.  Identification of polybacterial communities in patients with postoperative, posttraumatic, and endogenous endophthalmitis through 16S rRNA gene libraries.

Authors:  Rajagopalaboopathi Jayasudha; Venkatapathy Narendran; Palanisamy Manikandan; Solai Ramatchandirane Prabagaran
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

8.  High prevalence of fastidious bacteria in 1520 cases of uveitis of unknown etiology.

Authors:  Michel Drancourt; Pierre Berger; Céline Terrada; Bahram Bodaghi; John Conrath; Didier Raoult; Phuc LeHoang
Journal:  Medicine (Baltimore)       Date:  2008-05       Impact factor: 1.889

9.  Ocular manifestations of Whipple disease: an atypical presentation.

Authors:  J G Williams; D P Edward; H H Tessler; D H Persing; P S Mitchell; D A Goldstein
Journal:  Arch Ophthalmol       Date:  1998-09

10.  A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Authors:  Ellen Jo Baron; J Michael Miller; Melvin P Weinstein; Sandra S Richter; Peter H Gilligan; Richard B Thomson; Paul Bourbeau; Karen C Carroll; Sue C Kehl; W Michael Dunne; Barbara Robinson-Dunn; Joseph D Schwartzman; Kimberle C Chapin; James W Snyder; Betty A Forbes; Robin Patel; Jon E Rosenblatt; Bobbi S Pritt
Journal:  Clin Infect Dis       Date:  2013-07-10       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.